Microbiology and Immunology
James Koropatnick has not added Biography.
If you are James Koropatnick and would like to personalize this page please email our Author Liaison for assistance.
Reduction of copper and metallothionein in toxic milk mice by tetrathiomolybdate, but not deferiprone.
Journal of inorganic biochemistry Jan, 2002 | Pubmed ID: 11803042
The means to an end of tumor cell resistance to chemotherapeutic drugs targeting thymidylate synthase: shoot the messenger.
Current drug targets Aug, 2002 | Pubmed ID: 12102601
A sensitive time-resolved fluorescent immunoassay for metallothionein protein.
Journal of immunological methods Jan, 2003 | Pubmed ID: 12505728
A "combination oligonucleotide" antisense strategy to downregulate thymidylate synthase and decrease tumor cell growth and drug resistance.
Cancer gene therapy Apr, 2003 | Pubmed ID: 12679800
Signaling events for metallothionein induction.
Mutation research Dec, 2003 | Pubmed ID: 14643422
Metallothionein mediates the level and activity of nuclear factor kappa B in murine fibroblasts.
The Journal of pharmacology and experimental therapeutics Aug, 2004 | Pubmed ID: 15039454
Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology May, 2004 | Pubmed ID: 15117987
A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines.
The Journal of nutrition Jun, 2004 | Pubmed ID: 15173424
Toxicology of antisense therapeutics.
Toxicology and applied pharmacology Nov, 2004 | Pubmed ID: 15519609
Therapeutic potential of antisense oligodeoxynucleotides to down-regulate thymidylate synthase in mesothelioma.
Molecular cancer therapeutics Jun, 2006 | Pubmed ID: 16818500
Reinstalling antitumor immunity by inhibiting tumor-derived immunosuppressive molecule IDO through RNA interference.
Journal of immunology (Baltimore, Md. : 1950) Oct, 2006 | Pubmed ID: 17015752
In vivo inhibition of growth of human tumor lines by flavonoid fractions from cranberry extract.
Nutrition and cancer , 2006 | Pubmed ID: 17176222
Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells.
Cancer letters Jun, 2007 | Pubmed ID: 17197076
The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells.
The Journal of biological chemistry Jun, 2007 | Pubmed ID: 17392272
Combination silencer RNA (siRNA) targeting Bcl-2 antagonizes siRNA against thymidylate synthase in human tumor cell lines.
The Journal of pharmacology and experimental therapeutics Jul, 2007 | Pubmed ID: 17452420
Mouse monocytes (RAW CELLS) and the handling of cysteine and homocysteine S-conjugates of inorganic mercury and methylmercury.
Journal of toxicology and environmental health. Part A May, 2007 | Pubmed ID: 17454556
Induction of functional MT1 and MT2 isoforms by calcium in anaplastic thyroid carcinoma cells.
FEBS letters May, 2007 | Pubmed ID: 17485079
Antisense targeting of thymidylate synthase (TS) mRNA increases TS gene transcription and TS protein: effects on human tumor cell sensitivity to TS enzyme-inhibiting drugs.
Gene expression , 2007 | Pubmed ID: 17605297
ODN 491, a novel antisense oligodeoxynucleotide that targets thymidylate synthase, exerts cell-specific effects in human tumor cell lines.
DNA and cell biology May, 2008 | Pubmed ID: 18358073
Exosomes as a tumor immune escape mechanism: possible therapeutic implications.
Journal of translational medicine , 2008 | Pubmed ID: 18644158
Enhancement of cytotoxicity of natural product drugs against multidrug resistant variant cell lines of human head and neck squamous cell carcinoma and breast carcinoma by tesmilifene.
Cancer letters Feb, 2009 | Pubmed ID: 18986763
Expression of functional metallothionein isoforms in papillary thyroid cancer.
Molecular and cellular endocrinology Apr, 2009 | Pubmed ID: 19356627
Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?
Journal of translational medicine , 2011 | Pubmed ID: 21375761
Imaging of homeostatic, neoplastic, and injured tissues by HA-based probes.
Biomacromolecules Jan, 2012 | Pubmed ID: 22066590
Detection of circulating tumor cells in advanced head and neck cancer using the CellSearch system.
Head & neck Oct, 2012 | Pubmed ID: 22076949
Reduction of tumorigenicity by placental extracts.
Anticancer research Apr, 2012 | Pubmed ID: 22493344
Ki-67 expression predicts radiotherapy failure in early glottic cancer.
Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale Apr, 2012 | Pubmed ID: 22569013
Silencing IDO in dendritic cells: A novel approach to enhance cancer immunotherapy in a murine breast cancer model.
International journal of cancer. Journal international du cancer Feb, 2013 | Pubmed ID: 22870862
Frequent mutations in TP53 and CDKN2A found by next-generation sequencing of head and neck cancer cell lines.
Archives of otolaryngology--head & neck surgery Aug, 2012 | Pubmed ID: 22911296
A Pilot Study Comparing HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas by Whole Exome Sequencing.
ISRN oncology , 2012 | Pubmed ID: 23304554
Inhibition of BRCA2 and Thymidylate Synthase Creates Multidrug Sensitive Tumor Cells via the Induction of Combined "Complementary Lethality".
Molecular therapy. Nucleic acids , 2013 | Pubmed ID: 23481354
A case report and genetic characterization of a massive acinic cell carcinoma of the parotid with delayed distant metastases.
Case reports in oncological medicine , 2013 | Pubmed ID: 23653877
Does HPV type affect outcome in oropharyngeal cancer?
Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale , 2013 | Pubmed ID: 23663293
High frequency of activating PIK3CA mutations in human papillomavirus-positive oropharyngeal cancer.
JAMA otolaryngology-- head & neck surgery Jun, 2013 | Pubmed ID: 23787421
Imaging tumor growth non-invasively using expression of MagA or modified ferritin subunits to augment intracellular contrast for repetitive MRI.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging Feb, 2014 | Pubmed ID: 23836502
Metallothionein-I- and -II-deficient mice display increased susceptibility to cadmium-induced fetal growth restriction.
American journal of physiology. Endocrinology and metabolism Sep, 2013 | Pubmed ID: 23880315
Vaccinia virus outperforms a panel of other poxviruses as a potent oncolytic agent for the control of head and neck squamous cell carcinoma cell lines.
Intervirology , 2014 | Pubmed ID: 23942307
Non-covalently functionalized single-walled carbon nanotube for topical siRNA delivery into melanoma.
Biomaterials Mar, 2014 | Pubmed ID: 24424208
Targeted siRNA silencing of indoleamine 2, 3-dioxygenase in antigen-presenting cells using mannose-conjugated liposomes: a novel strategy for treatment of melanoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) Feb-Mar, 2014 | Pubmed ID: 24509175
Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, gamma radiation, and cisplatin.
Oncotarget May, 2014 | Pubmed ID: 24784564
Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy.
Journal of translational medicine , 2014 | Pubmed ID: 24884532
BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasis.
Molecular oncology Dec, 2014 | Pubmed ID: 24974076
Single-walled carbon nanotubes noncovalently functionalized with lipid modified polyethylenimine for siRNA delivery in vitro and in vivo.
Bioconjugate chemistry Oct, 2014 | Pubmed ID: 25216445
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved